Seres Therapeutics Inc (MCRB)
0.787
-0.01
(-1.02%)
USD |
NASDAQ |
Nov 05, 10:28
Seres Therapeutics Debt to Equity Ratio
Debt to Equity Ratio Chart
Historical Debt to Equity Ratio Data
| Date | Value |
|---|---|
| December 31, 2023 | -2.264 |
| September 30, 2023 | -6.688 |
| June 30, 2023 | 4.455 |
| March 31, 2023 | -1.070 |
| December 31, 2022 | 4.734 |
| September 30, 2022 | 0.7525 |
| June 30, 2022 | 2.196 |
| March 31, 2022 | 0.623 |
| December 31, 2021 | 0.1874 |
| September 30, 2021 | 0.1449 |
| June 30, 2021 | 0.2507 |
| March 31, 2021 | 0.1754 |
| December 31, 2020 | 0.1436 |
| September 30, 2020 | 0.1328 |
| June 30, 2020 | -0.3792 |
| March 31, 2020 | -0.4015 |
| Date | Value |
|---|---|
| December 31, 2019 | -0.5101 |
| September 30, 2019 | 0.00 |
| June 30, 2019 | 0.00 |
| March 31, 2019 | 0.00 |
| December 31, 2018 | 0.00 |
| September 30, 2018 | 0.00 |
| June 30, 2018 | 0.00 |
| March 31, 2018 | 0.00 |
| December 31, 2017 | 0.00 |
| September 30, 2017 | 0.00 |
| June 30, 2017 | 0.00 |
| March 31, 2017 | 0.00 |
| December 31, 2016 | 0.00 |
| September 30, 2016 | 0.00 |
| June 30, 2016 | 0.00 |
| March 31, 2016 | 0.00 |
Debt to Equity Ratio Definition
The debt to equity ratio measures the (Long Term Debt + Current Portion of Long Term Debt) / Total Shareholders' Equity. This metric is useful when analyzing the health of a company's balance sheet.
Debt to Equity Ratio Range, Past 5 Years
-6.688
Minimum
Sep 2023
4.734
Maximum
Dec 2022
0.146
Average
0.1449
Median
Sep 2021
Debt to Equity Ratio Benchmarks
| Chimerix Inc | 0.00 |
| Cellectar Biosciences Inc | -- |
| Marinus Pharmaceuticals Inc | -1.196 |
| Jaguar Health Inc | 1.948 |
| PDS Biotechnology Corp | -- |
Debt to Equity Ratio Related Metrics
| Total Assets (Quarterly) | 321.73M |
| Total Liabilities (Quarterly) | 408.80M |
| Shareholders Equity (Quarterly) | -87.07M |